Scientific Sessions 2025  /  TCT at AHA: ACS/STEMI: What We Have Accomplished and Where We Are Going  /  Optimal Anti-Thrombotic Therapy in Acute MI
Logo

American Heart Association

  30
  0

Final ID:

Optimal Anti-Thrombotic Therapy in Acute MI

  • Lopes, Renato  ( DUKE CLINICAL RESEARCH , Durham , North Carolina , United States )
    • Author Disclosures:
    Renato Lopes: DO have relevant financial relationships ; Consultant:Pfizer:Active (exists now) ; Consultant:Medtronic:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Past (completed) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Bayer:Past (completed) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Daiichi Sankyo:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: ACS/STEMI: What We Have Accomplished and Where We Are Going

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Mehran Roxana

Intracoronary Imaging in Culprit and Non-Culprit Revascularization of ACS

Pinilla Natalia, Mintz Gary, Al-azizi Karim

More abstracts from these authors:
ANALYSIS OF GUIDELINES IN VASCULAR NEUROLOGY AND STROKE PUBLISHED BETWEEN 2012 AND 2023.

Martins Hanna, Peixoto Vitória, De Souza Jorge Luiz, Gomes Gustavo, Andrade Joao, Sampaio Gisele, Lopes Renato, Santos Marcella, Ikeda Raissa, Sanchez Nascimento Paula, Romera Lopes Carlos Felipe, Mauricio Rebeca

Discussant: ANSWER-HF

Pfeffer Marc, Solomon Scott, Lopes Renato

You have to be authorized to contact abstract author. Please, Login
Not Available